| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 7.655 | 16.220 | 17.423 | 17.821 | 26.105 | 31.600 | 35.255 | 37.365 |
| Total Income - EUR | - | - | 7.655 | 16.220 | 17.423 | 17.821 | 26.105 | 31.600 | 35.255 | 37.365 |
| Total Expenses - EUR | - | - | 958 | 2.828 | 2.974 | 2.729 | 3.648 | 4.800 | 6.568 | 4.358 |
| Gross Profit/Loss - EUR | - | - | 6.698 | 13.392 | 14.449 | 15.091 | 22.457 | 26.799 | 28.687 | 33.007 |
| Net Profit/Loss - EUR | - | - | 6.468 | 12.906 | 13.926 | 14.596 | 21.674 | 25.870 | 24.648 | 27.832 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rejedemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 0 | 19 | 65 | 80 | 64 | 75 | 75 |
| Current Assets | - | - | 6.663 | 16.325 | 28.380 | 42.473 | 57.941 | 27.684 | 28.498 | 80.669 |
| Inventories | - | - | 0 | 0 | 71 | 69 | 68 | 68 | 0 | 0 |
| Receivables | - | - | 590 | 686 | 645 | 883 | 1.899 | 6.835 | 1.790 | 25.129 |
| Cash | - | - | 6.072 | 15.639 | 27.665 | 41.521 | 55.974 | 20.780 | 26.709 | 55.540 |
| Shareholders Funds | - | - | 6.512 | 14.570 | 28.214 | 42.275 | 57.756 | 25.911 | 26.588 | 29.762 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 178 | 1.755 | 185 | 264 | 265 | 1.837 | 1.985 | 50.982 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rejedemed Srl